Skip To Content

Participating in open and frank conversations can be a catalyst for both positive change and a better industry. As we share our perspective you will find:

  • Relevant and timely industry information
  • Medication trends, and their impact
  • Case studies, and the results of their related projects
  • Special-subject on-demand webinars

Articles, blogs and podcasts 

Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.

September 28, 2021 · Public Policy & Regulatory Affairs Team
Read more...
September 23, 2021 · Public Policy & Regulatory Affairs Team
Medical Marijuana – A New York appellate court recently ruled that an injured worker was entitled to a variance from the Medical Treatment Guidelines (MTGs) for the use of medical marijuana for his chronic pain. Read more...
September 16, 2021 · Medicare Insights Team
Approved by the FDA in August 2021, the first generic of Duexis, ibuprofen-famotidine, is now available and is included in the Workers’ Compensation Medicare Set-Aside Portal (WCMSAP) as of September 2021. Read more...
September 09, 2021 · David Young, President & CEO
As we approach the 20th anniversary of the devastating terror attacks that took the lives of nearly 3,000 lives on September 11, 2001, we remember those who lost their lives and honor the brave first responders who selflessly put their lives on the line to help others. Read more...
September 02, 2021 · Public Policy & Regulatory Affairs Team
The New York Workers’ Compensation Board (WCB) has published a final rule adopting changes to the drug formulary. Read more...
September 01, 2021 · Public Policy & Regulatory Affairs Team
This episode of the Policy Guys podcast/video tackles the tough subject of Post-Traumatic Stress Disorder (PTSD). Read more...
     Next >>
Page 1 of 17

Subscribe today to receive our latest blogs, articles, podcasts and more.